Tissue Regenix Share Discussion Threads

[holdingtight] 24/2/2020 16:57

I don't think they've started yet. Could be that they won't. Perhaps what's holding us back is the pending forward finance arrangement. Once confirmed, if satisfactory, this will hopefully take off.

[holdingtight] 24/2/2020 11:15

Plenty of trading and more buys than sells and no price movement at all !Odd.

[jibba jabber] 13/2/2020 09:01

ORM AGM today, buyers piling in

[nxc] 11/2/2020 19:02

A rights issue is more costly than a placing - they should do a placing and open offer

[monster500] 11/2/2020 16:42

If all goes well with all that's been mentioned in rns to date (expansion, shift increase, more production sales) profit increase will solve everything. :)

[the stigologist] 11/2/2020 16:02

ETX today illustrative. Sometimes a capital raise can be good. TRX need to sort out their balance sheet. The risk premia attached to the stock due to financing concern is larger than that of equity dilution. A Rights Issue would be the best way to proceed. Get a Rights Issue away at 0.5p or 1p and the stock will go up to 1p to 2p giving investors immediate 50-100% uplift IMO

[smokingjoe] 11/2/2020 15:47

Why would there be a fundraise ? They have 10.5m they can draw down through Midcap , the report was for restructuring, no placing coming here they have plenty of partners who would be more than happy to help

[sharetimebuy] 11/2/2020 14:06

UPDATED broker note --- New broker note http://bit.ly/2RCVKIH

[cerrito] 11/2/2020 13:54

Hardman's report was for me much better than is normal and good to see it clear that TRX need the equity injection which Hardman have modelled at £9m to get out of what Hardman describe as the catch 22 situation of financing the expansion in San Antonio that TRX need to take the business forward. Given the increase in long term debt as well as EBIT losses forecast in 2021, this £9m figure does not seem unreasonable. I have not kicked the tyres of their report too hard-but not sure why their cash flow forecast has £3.6m interest expense in 2021. As the Hardman report makes clear they have a week shareholder base-and of course no FD with City links. On the basis that a new fund raise would be at 1p per share we are looking at 900m shares being issued compared to their current 1172m shares in issue-and we are forgetting about the actual costs of the share increase. I am not sure what is to be gained by waiting-although on the basis that John Glen the NED may have more time on his hands as the CSRT takeover is finalized ,he can spend some time sorting this. I bought in too early 4 weeks ago and well done to those who sold at 1.7p a couple of weeks back. Views welcome.

[monster500] 11/2/2020 12:32

Some nice buy trades this morning. Looking good for the afternoon. :)

[jibba jabber] 11/2/2020 09:02

Yes, never did get that tr-1 did we?

[holdingtight] 10/2/2020 14:50

Hardly crazy.. a million of these is only £10k. PIs moving money about probably. Progress on the financing will see us fly.

[theapplefreak] 10/2/2020 13:25

The volume continues to be crazy here. Woodie got to be gone soon.

[grahamburn] 06/2/2020 09:17

https://www.hardmanandco.com/research/corporate-research/restructured-to-satisfy-product-demand/

[the stigologist] 06/2/2020 08:06

"The shares are trading at a discount of 87% to the £95.8m (8.2p per share) that has been invested in the company to date."

[the stigologist] 05/2/2020 00:49

In the risers, biotech group Tissue Regenix surged 17.5 per cent, or 0.17p, to 1.18p, following restoration of its critical IT systems after a cybersecurity breach last week. htTps://www.thisismoney.co.uk/money/markets/article-7967291/MARKET-REPORT-bad-news-post-Royal-Mail-investors.html

[monster500] 04/2/2020 14:13

Looking good some really big buys today:)

[amrishbhim] 04/2/2020 13:06

That's excellent news, at least it back!